MKMoshe Kotler

Moshe Kotler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Moshe Kotler has a total of 81 co-authors. Here are the top co-authors by number of shared publications:

  • Edan Kenig

    Department of Pathology and Lautenberg Center for General and Tumor Immunology, Jerusalem 91120, Israel

    2 shared publications
  • Elena Britan‐Rosich

    Department of Pathology and Immunology The Lautenberg Center for Immunology and Cancer Research The Hebrew University Hadassah Medical School Jerusalem Israel

    2 shared publications
  • Gunjan Sharma

    Department of Pathology and Immunology, The Lautenberg Center for Immunology and Cancer Research The Hebrew University Hadassah Medical School Jerusalem Israel

    2 shared publications
  • Ofra Moshel

    Core Research Facility, Institute for Drug Research, School of Pharmacy, Faculty of Medicine The Hebrew University‐Hadassah Medical School Jerusalem Israel

    2 shared publications
  • Ponnandy Prabhu

    Department of Pathology and Immunology, the Lautenberg Center for General and Tumor Immunology, The Hebrew University-Hadassah Medical School, Jerusalem, Israel

    2 shared publications
  • Roni Nowarski

    Department of Pathology and Lautenberg Center for General and Tumor Immunology, Jerusalem 91120, Israel

    2 shared publications

Latest Publications

  • Open Access

    APOBEC3G protects the genome of human cultured cells and mice from radiation‐induced damage

    by Yelena Britan‐Rosich, Jing Ma, Eran Kotler, Faizan Hassan, Alexander Botvinnik, Yoav Smith, Ofra Moshel, Abed Nasereddin, Gunjan Sharma, Eli Pikarsky, et al.

    Cytosine deaminases AID/APOBEC proteins act as potent nucleic acid editors, playing important roles in innate and adaptive immunity. However, the mutagenic effects of some of these proteins compromise genomic integrity and may promote tumorigenesis. Here, we demonstrate that human APOBEC3G (A3G), in addition to its role in innate immunity, promotes repair of double-strand breaks (DSBs) in vitro and in vivo. Transgenic mice expressing A3G successfully survived lethal irradiation, whereas wild-type controls quickly succumbed to radiation syndrome. Mass spectrometric analyses identified the differential upregulation of a plethora of proteins involved in DSB repair pathways in A3G-expressing cells early following irradiation to facilitate repair. Importantly, we find that A3G not only accelerates DSB repair but also promotes deamination-dependent error-free rejoining. These findings have two implications: (a) strategies aimed at inhibiting A3G may improve the efficacy of genotoxic therapies used to cure malignant tumours; and (b) enhancing A3G activity may reduce acute radiation syndrome in individuals exposed to ionizing radiation.


  • Open Access

    APOBEC3G rescues cells from the deleterious effects of DNA damage

    by Alexander Botvinnik, Pushkar Shivam, Yoav Smith, Gunjan Sharma, Udy Olshevsky, Ofra Moshel, Zakhariya Manevitch, Nuria Climent, Harold Oliva, Elena Britan‐Rosich, et al.

    Human apolipoprotein B mRNA editing enzyme, catalytic polypeptide‐like 3G (hA3G), a member of the APOBEC family, was described as an anti‐HIV‐1 restriction factor, deaminating reverse transcripts of the HIV‐1 genome. Several types of cancer cells that express high levels of A3G, such as diffuse large B‐cell lymphoma cells and glioblastomas, show enhanced cell survival after ionizing radiation (IR) and chemotherapy treatments. Previously, we showed that hA3G promotes (DNA) double‐strand breaks repair in cultured cells and it rescues transgenic mice from lethal IR dose. Here we show that A3G rescues cells from the detrimental effects of DNA damage induced by ultraviolet radiation (UV) and by combined bromodeoxyuridine and UV treatments. The combined treatments stimulate the synthesis of cellular proteins, which are exclusively associated with A3G expression. These proteins participate mainly in nucleotide excision repair and homologous recombination DNA repair pathways. Our results implicate A3G inhibition as a potential strategy for increasing tumor cells sensitivity to genotoxic treatments.


  • Validation of a KHV antibody enzyme‐linked immunosorbent assay (ELISA)

    by S M Bergmann, Q Wang, W Zeng, Y Li, Y Wang, M Matras, M Reichert, D Fichtner, M Lenk, T Morin, et al.

    Koi herpesvirus (KHV) causes KHV disease (KHVD). The virus is highly contagious in carp or koi and can induce a high mortality. Latency and, in some cases, a lack of signs presents a challenge for virus detection. Appropriate immunological detection methods for anti‐KHV antibodies have not yet been fully validated for KHV. Therefore, it was developed and validated an enzyme‐linked immunosorbent assay (ELISA) to detect KHV antibodies. The assay was optimized with respect to plates, buffers, antigens and assay conditions. It demonstrated high diagnostic and analytical sensitivity and specificity and was particularly useful at the pond or farm levels. Considering the scale of the carp and koi industry worldwide, this assay represents an important practical tool for the indirect detection of KHV, also in the absence of clinical signs.


  • Open Access

    Inhibition of APOBEC3G activity impedes double‐stranded DNA repair

    by Ponnandy Prabhu, Shivender M. D. Shandilya, Elena Britan‐Rosich, Adi Nagler, Celia A. Schiffer, Moshe Kotler

    The cellular cytidine deaminase APOBEC3G (A3G) was first described as an anti‐HIV‐1 restriction factor, acting by directly deaminating reverse transcripts of the viral genome. HIV‐1 Vif neutralizes the activity of A3G, primarily by mediating degradation of A3G to establish effective infection in host target cells. Lymphoma cells, which express high amounts of A3G, can restrict Vif‐deficient HIV‐1. Interestingly, these cells are more stable in the face of treatments that result in double‐stranded DNA damage, such as ionizing radiation and chemotherapies. Previously, we showed that the Vif‐derived peptide (Vif25–39) efficiently inhibits A3G deamination, and increases the sensitivity of lymphoma cells to ionizing radiation. In the current study, we show that additional peptides derived from Vif, A3G, and APOBEC3F, which contain the LYYF motif, inhibit deamination activity. Each residue in the Vif25–39 sequence moderately contributes to the inhibitory effect, whereas replacing a single residue in the LYYF motif completely abrogates inhibition of deamination. Treatment of A3G‐expressing lymphoma cells exposed to ionizing radiation with the new inhibitory peptides reduces double‐strand break repair after irradiation. Incubation of cultured irradiated lymphoma cells with peptides that inhibit double‐strand break repair halts their propagation. These results suggest that A3G may be a potential therapeutic target that is amenable to peptide and peptidomimetic inhibition.


  • Open Access

    Mortality Caused by Bath Exposure of Zebrafish (Danio rerio) Larvae to Nervous Necrosis Virus Is Limited to the Fourth Day Postfertilization

    by Danny Morick, Or Faigenbaum, Margarita Smirnov, Yakov Fellig, Adi Inbal, Moshe Kotler

    Nervous necrosis virus (NNV) is a member of the Betanodavirus genus that causes fatal diseases in over 40 species of fish worldwide. Mortality among NNV-infected fish larvae is almost 100%. In order to elucidate the mechanisms responsible for the susceptibility of fish larvae to NNV, we exposed zebrafish larvae to NNV by bath immersion at 2, 4, 6, and 8 days postfertilization (dpf). Here, we demonstrate that developing zebrafish embryos are resistant to NNV at 2 dpf due to the protection afforded by the egg chorion and, to a lesser extent, by the perivitelline fluid. The zebrafish larvae succumbed to NNV infection during a narrow time window around the 4th dpf, while 6- and 8-day-old larvae were much less sensitive, with mortalities of 24% and 28%, respectively.


  • APOBEC3G Inhibits HIV-1 RNA Elongation by Inactivating the Viral Trans-Activation Response Element

    by Roni Nowarski, Ponnandy Prabhu, Edan Kenig, Yoav Smith, Elena Britan-Rosich, Moshe Kotler


  • Hematological and Cardiometabolic Safety of Clozapine in the Treatment of Very Early Onset Schizophrenia: A Retrospective Chart Review

    by Yael Midbari, Tanya Ebert, Ira Kosov, Moshe Kotler, Abraham Weizman, Anca Ram

    There are very few studies in the literature regarding clozapine use in children 100 beats per minute) at release from the hospital, compared with only one child (5%) in the control group (p=0.006). It appears that clozapine use in very early onset schizophrenia is safe. Although hematological adverse effects did occur in our study, the rates were not much higher than those seen in the control group. We found that the hematological abnormalities in the CTG were mostly transient, and that treatment with clozapine can be safely continued or renewed.


  • Open Access

    APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair

    by Roni Nowarski, Ofer I. Wilner, Ori Cheshin, Or D. Shahar, Edan Kenig, Leah Baraz, Elena Britan-Rosich, Arnon Nagler, Reuben S. Harris, Michal Goldberg, et al.

    APOBEC3 proteins catalyze deamination of cytidines in single-stranded DNA (ssDNA), providing innate protection against retroviral replication by inducing deleterious dC > dU hypermutation of replication intermediates. APOBEC3G expression is induced in mitogen-activated lymphocytes; however, no physiologic role related to lymphoid cell proliferation has yet to be determined. Moreover, whether APOBEC3G cytidine deaminase activity transcends to processing cellular genomic DNA is unknown. Here we show that lymphoma cells expressing high APOBEC3G levels display efficient repair of genomic DNA double-strand breaks (DSBs) induced by ionizing radiation and enhanced survival of irradiated cells. APOBEC3G transiently accumulated in the nucleus in response to ionizing radiation and was recruited to DSB repair foci. Consistent with a direct role in DSB repair, inhibition of APOBEC3G expression or deaminase activity resulted in deficient DSB repair, whereas reconstitution of APOBEC3G expression in leukemia cells enhanced DSB repair. APOBEC3G activity involved processing of DNA flanking a DSB in an integrated reporter cassette. Atomic force microscopy indicated that APOBEC3G multimers associate with ssDNA termini, triggering multimer disassembly to multiple catalytic units. These results identify APOBEC3G as a prosurvival factor in lymphoma cells, marking APOBEC3G as a potential target for sensitizing lymphoma to radiation therapy.


  • Open Access

    Herpesviruses that Infect Fish

    by Larry Hanson, Arnon Dishon, Moshe Kotler

    Herpesviruses are host specific pathogens that are widespread among vertebrates. Genome sequence data demonstrate that most herpesviruses of fish and amphibians are grouped together (family Alloherpesviridae) and are distantly related to herpesviruses of reptiles, birds and mammals (family Herpesviridae). Yet, many of the biological processes of members of the order Herpesvirales are similar. Among the conserved characteristics are the virion structure, replication process, the ability to establish long term latency and the manipulation of the host immune response. Many of the similar processes may be due to convergent evolution. This overview of identified herpesviruses of fish discusses the diseases that alloherpesviruses cause, the biology of these viruses and the host-pathogen interactions. Much of our knowledge on the biology of Alloherpesvirdae is derived from research with two species: Ictalurid herpesvirus 1 (channel catfish virus) and Cyprinid herpesvirus 3 (koi herpesvirus).


  • Paroxetine in panic disorder: clinical management and long-term follow-up

    by Pinhas N Dannon, Katherine Lowengrub, I Iancu, Moshe Kotler

    Panic disorder is one of the most common anxiety disorders and has a lifetime prevalence of 3-5%. Panic attacks can begin at any age, but commonly have their onset in early adulthood between the ages of 20 and 40 years. Naturalistic data has shown that panic disorder has a chronic and relapsing course. Panic disorder is reported to be associated with an increased risk of suicidal behavior and comorbid psychiatric diagnoses such as depression and substance abuse. Currently, recommended treatment modalities for panic disorder include the use of antidepressant pharmacotherapy and/or cognitive behavioral therapy. Paroxetine is unique among the selective serotonin reuptake inhibitors since, in addition to its effect on the CNS serotonergic neurotransmission, it also has mild noradrenergic properties demonstrated to be effective in the treatment of anxiety disorders and depression. Paroxetine treatment has the potential to cause weight gain and sexual dysfunction, primarily anorgasmia and ejaculatory dysfunction for the long term. In the short-term, treatment causes nausea, gastrointestinal disturbances, irritability, headaches and eating and sleeping difficulties. Paroxetine is an example of an selective serotonin reuptake inhibitor agent, which has been well studied in the treatment of panic disorder and is efficacious and well-tolerated. Paroxetine pharmacotherapy has been recommended to be continued for 1 year as specified in the treatment guidelines set by the American Psychiatric Association in the treatment of panic disorder.